1-methyl-4-phenylpyridinium has been researched along with Encephalopathy, Toxic in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 5 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Biagioni, F; Busceti, CL; Ferrucci, M; Fornai, F; Frati, A; Lazzeri, G; Lenzi, P; Puglisi-Allegra, S | 1 |
| Bae, JE; Cho, DH; Jo, DS; Jung, YK; Kim, JB; Kim, P; Kim, SH; Kim, YH; Lee, HJ; Lee, HS; Lee, WH; Park, NY; Ryoo, ZY; Ryu, HY; Son, M | 1 |
| Song, L; Xiao, Z; Xie, J; Xu, H; Yu, X; Zhang, N | 1 |
| Cao, F; Chen, P; Duan, JA; Guo, S; Liu, C; Liu, J; Qian, B; Qian, D; Wang, Y; Xu, C; Yan, Y; Zhang, F; Zhang, X | 1 |
| Dong, L; He, Z; Liu, N; Luo, X; Zheng, Y | 1 |
| Chakraborty, S; Chiou, A; Karmenyan, A; Tsai, JW | 1 |
| Cho, SW; Choi, SY; Ha, JS; Na, JM; Yang, JW; Yang, SJ | 1 |
| Ahn, TB; Baek, JY; Bok, E; Cho, EJ; Chung, YC; Jeong, JY; Jin, BK; Kim, KI; Nam, JH; Shin, WH; Won, SY | 1 |
| Dou, D; Jia, D; Kang, T; Li, D; Liu, Q; Wang, X | 1 |
| de Pablos, RM; Espinosa-Oliva, AM; Santiago, M | 1 |
| Adam, M; Brunner, T; Farhan, H; Förster, S; Gutbier, S; Hartung, T; Hiller, K; Ivanova, V; Jagtap, S; Krug, AK; Kullmann, C; Leist, M; Leparc, G; Meiser, J; Pöltl, D; Sachinidis, A; Schildknecht, S; Zhao, L | 1 |
| Jia, Y; Lu, H; Lu, J; Peng, T; Teng, J; Wang, J | 1 |
| Chan, HM; Figeys, D; Mailloux, R; Ning, Z; Shao, Y | 1 |
| Chen, WF; Chen, XH; Jiang, MC; Xu, AL | 1 |
| Bang, HS; Kim, DG; Kim, SH; Kim, SY; Ko, H; Kwon, HC; Oh, DC; Park, SH; Shin, J | 1 |
| Murthy, V; Ramassamy, C; Singh, M | 1 |
| Daya, S; Maharaj, DS; Maharaj, H; Mohanakumar, KP; Saravanan, KS | 1 |
| Jin, J; Kovacs, M; Wang, Y; Zhang, J; Zhou, Y | 1 |
| Ali, SF; Cawthon, D; Duhart, HM; Fang, H; McCastlain, KA; Newport, GD; Patterson, TA; Slikker, W; Xu, Z | 1 |
| Dryhurst, G; Foster, SB; Miller, KE; Tang, H | 1 |
| Barkats, M; Colin, P; Faucon-Biguet, N; Horellou, P; Mallet, J; Millecamps, S | 1 |
| Liu, R; Shang, Y; Sun, S; Wu, Y | 1 |
| Rojas, C; Rojas, P; Rojas-Castañeda, J; Vigueras, RM | 1 |
23 other study(ies) available for 1-methyl-4-phenylpyridinium and Encephalopathy, Toxic
| Article | Year |
|---|---|
Bacopa Protects against Neurotoxicity Induced by MPP
Topics: 1-Methyl-4-phenylpyridinium; Bacopa; Catecholamines; Methamphetamine; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Reactive Oxygen Species | 2022 |
Carnitine Protects against MPP
Topics: 1-Methyl-4-phenylpyridinium; Acetylcarnitine; Apoptosis; Carnitine; Cell Line, Tumor; Dopaminergic Neurons; Humans; Inflammation; Neuroblastoma; Neurotoxicity Syndromes | 2022 |
Ferritin confers protection against iron-mediated neurotoxicity and ferroptosis through iron chelating mechanisms in MPP
Topics: 1-Methyl-4-phenylpyridinium; Apoferritins; Ferritins; Ferroptosis; Humans; Iron; Iron Chelating Agents; Neurotoxicity Syndromes | 2022 |
An acidic heteropolysaccharide from Lycii fructus: Purification, characterization, neurotrophic and neuroprotective activities in vitro.
Topics: 1-Methyl-4-phenylpyridinium; Acids; Animals; Lycium; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinsonian Disorders; PC12 Cells; Plant Extracts; Polysaccharides; Rats | 2020 |
Mir-141-3p Regulates Apoptosis and Mitochondrial Membrane Potential via Targeting Sirtuin1 in a 1-Methyl-4-Phenylpyridinium in vitro Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Cell Differentiation; Cytokines; Disease Models, Animal; Membrane Potential, Mitochondrial; MicroRNAs; Nerve Growth Factor; Neurites; Neurotoxicity Syndromes; Oxidative Stress; Parkinson Disease; PC12 Cells; Rats; Reactive Oxygen Species; Sirtuin 1 | 2020 |
Inhibitory effects of curcumin and cyclocurcumin in 1-methyl-4-phenylpyridinium (MPP
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Differentiation; Cell Survival; Curcumin; Microscopy, Fluorescence; NAD; Nerve Growth Factor; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinson Disease; PC12 Cells; Rats; Reactive Oxygen Species | 2017 |
3-(Naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride attenuates MPP＋-induced cytotoxicity by regulating oxidative stress and mitochondrial dysfunction in SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Azetidines; Cell Line, Tumor; Cytoprotection; Humans; Microglia; Mitochondria; Naphthalenes; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2018 |
Inhibition of Microglia-Derived Oxidative Stress by Ciliary Neurotrophic Factor Protects Dopamine Neurons In Vivo from MPP⁺ Neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; Aged; Animals; Astrocytes; Capsaicin; Cell Survival; Ciliary Neurotrophic Factor; Dopaminergic Neurons; Female; Gene Knockdown Techniques; Humans; Male; Microglia; Models, Biological; Nerve Degeneration; Neuroprotection; Neurotoxicity Syndromes; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Ciliary Neurotrophic Factor; RNA, Small Interfering; Substantia Nigra; TRPV Cation Channels | 2018 |
Protective effect of arctigenin against MPP+ and MPTP-induced neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Brain; Cell Line, Tumor; Cell Survival; Dopamine; Furans; gamma-Aminobutyric Acid; Humans; Lignans; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroblastoma; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinson Disease | 2014 |
In vivo effect of apomorphine and haloperidol on MPP neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Microdialysis; Neuroprotective Agents; Neurotoxicity Syndromes; Rats; Rats, Wistar | 2014 |
Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+).
Topics: 1-Methyl-4-phenylpyridinium; Activating Transcription Factor 4; Adaptation, Physiological; Adenosine Triphosphate; Cell Line; Computational Biology; Dopaminergic Neurons; Energy Metabolism; Gene Expression Profiling; Gene Expression Regulation; Glucose; Glutathione; High-Throughput Nucleotide Sequencing; Humans; Mass Spectrometry; Metabolomics; Mitochondria; Neural Stem Cells; Neurotoxicity Syndromes; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Phosphocreatine; RNA Interference; Time Factors; Transcription, Genetic; Transfection | 2014 |
Neuroprotective effects of α-melanocyte-stimulating hormone against the neurotoxicity of 1-methyl-4-phenylpyridinium.
Topics: 1-Methyl-4-phenylpyridinium; Adenosine Triphosphate; alpha-MSH; Cell Line, Tumor; Cell Survival; Cytochromes c; Humans; Membrane Potential, Mitochondrial; Neuroblastoma; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinson Disease; Reactive Oxygen Species | 2017 |
Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.
Topics: 1-Methyl-4-phenylpyridinium; Cells, Cultured; Dopamine; Dopaminergic Neurons; Energy Metabolism; Genome; Genomics; Humans; Methylmercury Compounds; Neurotoxicity Syndromes; Oxidative Phosphorylation; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Proteome; Proteomics; Signal Transduction; Tyrosine 3-Monooxygenase; Ubiquitin-Conjugating Enzymes | 2015 |
Icariin protects against MPP
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Caspase 3; Cell Line; Cell Survival; Down-Regulation; Flavonoids; Membrane Potential, Mitochondrial; Mitochondria; Neuroprotective Agents; Neurotoxicity Syndromes; RNA, Messenger; Up-Regulation | 2016 |
Coprismycins A and B, neuroprotective phenylpyridines from the dung beetle-associated bacterium, Streptomyces sp.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Line, Tumor; Cell Survival; Coleoptera; Dopamine; Drug Discovery; Molecular Structure; Neuroblastoma; Neuroprotective Agents; Neurotoxicity Syndromes; Oximes; Parkinsonian Disorders; Pyridines; Streptomyces | 2011 |
Standardized extracts of Bacopa monniera protect against MPP+- and paraquat-induced toxicity by modulating mitochondrial activities, proteasomal functions, and redox pathways.
Topics: 1-Methyl-4-phenylpyridinium; Antioxidants; Bacopa; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Electron Transport Complex I; Glutathione; Humans; Membrane Potential, Mitochondrial; Mitochondria; Neuroprotective Agents; Neurotoxicity Syndromes; NF-E2-Related Factor 2; Oxidation-Reduction; Paraquat; Plant Extracts; Proteasome Endopeptidase Complex; Reactive Oxygen Species | 2012 |
Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetaminophen; Analgesics, Non-Narcotic; Animals; Aspirin; Dopamine; Dopamine Agents; Lipid Peroxidation; Male; Neostriatum; Neurotoxicity Syndromes; Neurotoxins; Nitroblue Tetrazolium; Prosencephalon; Rats; Rats, Sprague-Dawley; Superoxides | 2004 |
Microglial activation induced by neurodegeneration: a proteomic analysis.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cells, Cultured; Culture Media, Conditioned; Ethylenebis(dithiocarbamates); Membrane Proteins; Microglia; Nerve Degeneration; Neurons; Neurotoxicity Syndromes; Organometallic Compounds; Proteome; Proteomics; Rats; Rats, Sprague-Dawley | 2005 |
Selective alterations of transcription factors in MPP+-induced neurotoxicity in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Survival; DNA; Dopamine; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Kinetics; Neurotoxicity Syndromes; Neurotransmitter Agents; Oligonucleotide Array Sequence Analysis; PC12 Cells; Protein Binding; Rats; Transcription Factors | 2005 |
Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acids; Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Electrochemistry; Enzyme Inhibitors; Extracellular Space; gamma-Glutamyltransferase; Glutamic Acid; Glutathione; Immunohistochemistry; Isoxazoles; Male; Microdialysis; Neostriatum; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Serotonin | 2005 |
1-methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Count; Cell Line, Tumor; Disease Models, Animal; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Motor Activity; Neuroblastoma; Neurotoxicity Syndromes; Parkinson Disease; Rats; Rotarod Performance Test; Substantia Nigra; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Transgenes; Tyrosine 3-Monooxygenase | 2006 |
Antioxidant effect of erythropoietin on 1-methyl-4-phenylpyridinium-induced neurotoxicity in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Survival; Erythropoietin; Flow Cytometry; Humans; Membrane Potential, Mitochondrial; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; PC12 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Recombinant Proteins; Signal Transduction; Up-Regulation | 2007 |
Ginkgo biloba pretreatment partially protects from the dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Dopamine; Flavonoids; Ginkgo biloba; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Plant Extracts; Plants, Medicinal | 2000 |